CECCARELLI, FULVIA
 Distribuzione geografica
Continente #
NA - Nord America 7.876
EU - Europa 3.294
AS - Asia 2.496
SA - Sud America 230
AF - Africa 96
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.006
Nazione #
US - Stati Uniti d'America 7.788
IT - Italia 1.503
SG - Singapore 1.329
CN - Cina 506
IN - India 466
SE - Svezia 424
FI - Finlandia 248
RU - Federazione Russa 218
BR - Brasile 168
DE - Germania 166
UA - Ucraina 132
IE - Irlanda 108
GB - Regno Unito 98
CA - Canada 71
AT - Austria 62
ID - Indonesia 62
TG - Togo 60
BG - Bulgaria 58
FR - Francia 53
NL - Olanda 45
AR - Argentina 40
BE - Belgio 37
RO - Romania 33
HK - Hong Kong 31
CH - Svizzera 16
PL - Polonia 16
TR - Turchia 13
ZA - Sudafrica 12
ES - Italia 11
KR - Corea 11
MX - Messico 11
PH - Filippine 11
CL - Cile 9
HU - Ungheria 9
MA - Marocco 9
GR - Grecia 8
IL - Israele 8
LT - Lituania 8
MK - Macedonia 7
TH - Thailandia 7
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SA - Arabia Saudita 6
AU - Australia 5
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
OM - Oman 4
DZ - Algeria 3
HR - Croazia 3
IR - Iran 3
JO - Giordania 3
JP - Giappone 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PK - Pakistan 3
SC - Seychelles 3
UZ - Uzbekistan 3
VE - Venezuela 3
BD - Bangladesh 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LY - Libia 1
SI - Slovenia 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.006
Città #
Fairfield 1.111
Chandler 653
Singapore 626
Ashburn 568
Rome 512
Woodbridge 511
Seattle 410
Houston 387
Dearborn 375
Wilmington 369
Cambridge 349
Ann Arbor 271
Princeton 242
San Paolo di Civitate 214
Santa Clara 210
Plano 173
Lawrence 166
Millbury 134
Beijing 112
Dublin 108
San Diego 101
Boston 99
Helsinki 93
Milan 91
New York 76
Andover 71
Lomé 60
Moscow 58
Sofia 58
Jakarta 57
Cosenza 43
San Mateo 42
Toronto 42
Jacksonville 40
Vienna 39
Des Moines 35
Falls Church 35
Brussels 33
Federal 33
Norwalk 33
Council Bluffs 28
Falkenstein 28
Hong Kong 27
Boardman 26
Fremont 24
Nanjing 23
Los Angeles 22
Nuremberg 22
Mannheim 21
Guangzhou 20
Kunming 20
Yubileyny 20
Ottawa 19
Phoenix 19
Southend 19
Jinan 18
Monterotondo 18
Hefei 17
Bühl 16
Florence 16
Padova 16
London 15
Shanghai 14
São Paulo 14
Warsaw 14
Frankfurt am Main 13
Naples 13
Palermo 12
Paris 12
Redwood City 11
Dallas 10
Pisa 10
Washington 10
Amsterdam 9
Formia 9
Stockholm 9
Athens 8
Frosinone 8
Grafing 8
Nanchang 8
Zurich 8
Bangkok 7
Bari 7
Brasília 7
Hyderabad 7
Rio de Janeiro 7
Treviso 7
Turin 7
Belo Horizonte 6
Bern 6
Bologna 6
Budapest 6
Buffalo 6
Gangbuk-gu 6
Latina 6
Mexico City 6
Santiago 6
Valenza 6
Zhengzhou 6
Auckland 5
Totale 9.414
Nome #
Validazione della versione italiana del lupus-qol, questionario malattia-specifico per la misurazione della qualità della vita relativa allo stato di salute in pazienti adulti affetti da lupus eritematoso sistemico 228
Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations 136
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs 133
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome 130
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 118
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus. 111
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models 110
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 110
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients 108
Efficacy of spa-therapy, mud-pack therapy, balneotherapy and mud-bath therapy in the management of knee osteoarthritis. A systematic review 107
Do Behçet's syndrome patients with acne and arthritis comprise a true subset? Comment on the article by Hatemi et al 106
Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-phospholipid Syndrome: Two Distinct Mechanisms? 106
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases 105
Treating lupus patients with antimalarials. analysis of safety profile in a single-center cohort 104
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 102
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 102
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study 101
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion 97
An overview on the genetic of rheumatoid arthritis: A never-ending story 95
A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene. 94
Porphyromonas gingivalis and rheumatoid arthritis 94
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 94
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 94
A study on the efficacy of treatment with mud packs and baths with Sillene mineral water (Chianciano Spa Italy) in patients suffering from knee osteoarthritis 93
The natural agonist of estrogen receptor β silibinin plays an immunosuppressive role representing a potential therapeutic tool in rheumatoid arthritis 93
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 91
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 90
Autophagy and rheumatoid arthritis: Current knowledges and future perspectives 89
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment 87
Musculoskeletal ultrasound in the evaluation of polymyalgia rheumatica 86
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 86
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows 86
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 85
The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA 85
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative antiphospholipid syndrome 85
Biological Drug Treatment of Rheumatoid Arthritis and Spondyloarthritis: Effects on QT Interval and QT Dispersion 85
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus 85
Role of scintigraphy with 99mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis 84
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 84
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 84
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 84
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 84
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach 83
The use of musculoskeletal ultrasound in a Rheumatology Outpatient Clinic. 83
Periodontitis and rheumatoid arthritis: the same inflammatory mediators? 83
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients 83
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 82
Developing new evaluation methods in systemic lupus erythematosus 82
Treatment with gonadotropin releasing hormone agonists in systemic lupus erythematosus patients receiving cyclophosphamide: a long-term follow-up study 82
Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study. 82
Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography 81
Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage 80
Microparticles and autophagy, a new frontier in the understanding of atherosclerosis in rheumatoid arthritis 80
Comprehensive disease control in systemic lupus erythematosus 80
Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome 80
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 79
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis 79
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study 79
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 78
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX 78
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities 78
Pregnancy outcome in systemic lupus erythematosus patients. a monocentric cohort analysis 77
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 76
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 75
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile 74
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al 73
HLA-DRB1 the notorious gene in the mosaic of autoimmunity 72
The Italian MSUS Study Group recommendations for the format and content of the report and documentation in musculoskeletal ultrasonography in rheumatology 72
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica 71
Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis 71
Smoke and autoimmunity: The fire behind the disease 70
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: A prospective observational multicentre study (MODERATE) 70
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. 70
Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor 70
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio 69
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation by Braaten et al: another point of view 69
Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis 67
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists 67
The Role of Ultrasound in Rheumatology 66
Serum sclerostin as a possible biomarker in ankylosing spondylitis. a case-control study 66
Fatigue and widespread pain in systemic lupus erythematosus and Sjogren's syndrome: symptoms of inflammatory disease or associated fibromyalgia? 66
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 65
Biological therapies in rheumatic diseases 65
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study 65
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. results of a large, multicentric, nationwide study 65
Diffusion and applications of musculoskeletal ultrasound in Italian Rheumatology Units 64
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells 64
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement 64
Genetics and autoantibodies. 64
Breastfeeding in women affected by systemic lupus erythematosus. rate, duration and associated factors 64
Autophagy hijacking in PBMC From COVID-19 patients results in lymphopenia 63
Effect of Etanercept on anti-carbamylated protein antibodies in patients with rheumatoid arthritis 63
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 63
Transforming growth factor β 869C/T and interleukin 6 -174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis 63
Premature ovarian failure in patients affected by systemic lupus erythematosus. a cross-sectional study 63
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus Nephritis: Correlation with Histologic Findings. 63
Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis 62
Genetic Factors of Autoimmune Diseases 62
Genetic diversity of staphylococcus aureus influences disease phenotype of systemic lupus erythematosus 62
Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome 61
Totale 8.379
Categoria #
all - tutte 54.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 0 0 0 0 0 0 0 0 218 159 94 50
2020/20211.076 87 119 37 42 41 42 57 105 168 168 131 79
2021/20222.488 36 136 218 174 327 121 50 227 197 183 363 456
2022/20232.698 456 615 131 234 286 263 25 182 263 67 138 38
2023/20241.503 83 180 78 81 101 175 77 116 55 212 180 165
2024/20252.852 103 189 196 344 257 328 347 246 842 0 0 0
Totale 14.653